Table 1.
Quality of Life Domains | Biological Pathways* | Candidate genes | Biomolecular markers | Literature |
---|---|---|---|---|
| ||||
Fatigue | • (1) | |||
| ||||
• Serotonergic synapse/metabolic pathway | • TPH1 | • 5-HT | • (2–5) | |
| ||||
• Dopaminergic synapse | • COMT, DRD4, DAT1 | • Cortisol | • (6, 7) | |
| ||||
• Glutathione metabolic pathway | • GSTZ1, ABCC4, DPYD, GSTP1, OPRT/UMPS | -NR- | • (8–10) | |
| ||||
• Inflammation | • Cytokine-cytokine receptor interaction | • (11) | ||
◆ pro-inflammatory | • IL-1β, IL-6, TNF-α, CD19+β | • IL-1β, IL-6, TNF-α, CD19+β, TNF-R1, | • (12–25) | |
◆ anti-inflammatory | • IL-1RN, IL-1Rα, IL-10 | • IL-1RN, IL-1Rα, IL-10 | • (13–15, 17) | |
◆ immunity | • IL-2, IL-4, IL-5, IFN-γ | • IL-2, IL-4, IL-5, IFN-γ | • (12, 26) | |
◆ cell migration | • CXCL9, CXCL11 | • CXCL9, CXCL11 | • (27) | |
◆ inflammation | • CRP | • CRP, neopterin | • (4, 13) | |
| ||||
• Cortisol production, serotonin dysregulation, catecholamine | • HPA | -NR- | • CRH, ACTH, cortisol, melatonin, norepinephrine, epinephrine | • (28–31) |
| ||||
• Circadian rhythm disruption – i.e. through modulation of arousal and sleep patterns | • SCN | • PER2, PER3, TIMELESS | • EGF, TGF-α, neuregulin-1, prokineticine-2, cardiotrophin-like cytokine, PER2, PER3, cortisol, melatonin | • (28, 32–37) |
| ||||
• EGFR | -NR- | -NR- | • (28) | |
| ||||
• Peripheral fatigue (muscle strength) | • Skeletal muscle | -NR- | • ATP | • (37, 38) |
| ||||
• Vagal afferent nerve activation (suppress somatic muscle activity – ‘sickness behavior’) | • Cytokine-cytokine receptor interaction | |||
◆ pro-inflammatory | • IL-1, IL-6, TNF-α | • IL-1, IL-6, TNF-α | • (39) |
Biological pathways are according to KEGG (Kyoto Encyclopaedia of Genes and Genomes), http://www.genome.jp/kegg/ or Genecards, http://www.genecards.org/
Note: References are included in Supplementary Material 2: References to Tables 1–7.
NR: the relevant information was not reported
?: the relevant biological pathway could not be identified